Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GOSS · as of Jun 8, 2026
Key Statistics
Explore Gossamer Bio, Inc. Data
goss stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 52.9%
The GOSS analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $0.77, representing +338.10% upside from the current price of $0.17.
Competitors & Peers
goss competitorsGOSS
CRVS
FDMT
KALV
LXRX
OLMAStock Performance
Full HistoryAbout Gossamer Bio, Inc.
Gossamer Bio, Inc. a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and on…
what is gossamer bio, inc. · goss stock overview · gossamer bio, inc. company profile · who is gossamer bio, inc. ceo · goss NASDAQ · gossamer bio, inc. headquarters · gossamer bio, inc. business segments
About Stock Overview & Key Data
Gossamer Bio, Inc. (GOSS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 8, 2019. As of the latest trading session, GOSS stock price is $0.17, with a market capitalization of $41.1M. The stock has returned -86.84% over the past 12 months and -94.35% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Gossamer Bio, Inc. stock is Buy, with an average 12-month price target of $0.77. In fiscal year 2025, Gossamer Bio, Inc. reported revenue of $48.5M and net income of -$170.4M. For detailed data — including Gossamer Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gossamer Bio, Inc. (GOSS) stock price is $0.17. The stock is traded on NASDAQ under the ticker symbol GOSS. The 52-week range is $0.16 – $3.87.